Eager to resolve the ever-growing number of lawsuits against opioid manufacturers and distributors, the judge overseeing multidistrict litigation in the United States is holding an "information session" on Jan. 31 with a group of plaintiffs and defendants. And in a sign of how significant the matter is, the court has invited someone from FDA to attend the meeting.
The goal of the gathering is to educate the court and the parties on supply-chain dynamics and other issues relevant...





